Bullboard - Stock Discussion Forum FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is... see more

Add To Watchlist

CSE:HUGE - Post Discussion

FSD Pharma Inc > FSD Pharma Drug Pipeline Time Frame Estimates

View:

Post by DavidRosenberg on Nov 12, 2021 8:40am

FSD Pharma Drug Pipeline Time Frame Estimates

 		Time lines for the 3 drugs

 		Phase 2 starts for PEA in 2022

 		phase 1 starts end of 2022 for the 2 new drug candidates candicates

 					FSD Pharma is taking a unique approach to deliver “Total Brain Health” to patients in need. Our mission is to treat the millions of people suffering from diseases by bringing innovative therapies to market. Through our wholly-owned subsidiary, Lucid Psycheceuticals, we have the exclusive worldwide rights to patented CNS compounds with the potential to treat progressive Multiple Sclerosis (“MS”). Additionally, FSD is developing a unique psychedelic-based therapeutic aimed to address a multibillion-dollar mental health market.
 					FSD Pharma has a pipeline of the following 3 drug candidates: